Liu et al. showed that exosomal circCARM1 derived from breast cancer stem cell (BCSC) spheroids could increase and reprogram cell metabolism by modulating PFKFB2 expression in BC, specifically impacting glycolysis through miR-1252-5p/PFKFB2 pathway [30]. This evidence concerns the gene PFKFB2 and breast carcinoma.